GB1585725A - Protein adsorbent and process for the production of urokinase - Google Patents
Protein adsorbent and process for the production of urokinase Download PDFInfo
- Publication number
- GB1585725A GB1585725A GB121578A GB121578A GB1585725A GB 1585725 A GB1585725 A GB 1585725A GB 121578 A GB121578 A GB 121578A GB 121578 A GB121578 A GB 121578A GB 1585725 A GB1585725 A GB 1585725A
- Authority
- GB
- United Kingdom
- Prior art keywords
- urokinase
- protein
- adsorbent
- international units
- column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 title claims description 57
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 title claims description 57
- 229960005356 urokinase Drugs 0.000 title claims description 57
- 102000004169 proteins and genes Human genes 0.000 title claims description 31
- 108090000623 proteins and genes Proteins 0.000 title claims description 31
- 239000003463 adsorbent Substances 0.000 title claims description 29
- 238000000034 method Methods 0.000 title claims description 18
- 238000004519 manufacturing process Methods 0.000 title description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 18
- 229920002684 Sepharose Polymers 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 238000004587 chromatography analysis Methods 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 9
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000011541 reaction mixture Substances 0.000 claims description 8
- 125000006850 spacer group Chemical group 0.000 claims description 8
- 238000000746 purification Methods 0.000 claims description 7
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 6
- 239000008351 acetate buffer Substances 0.000 claims description 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical group 0.000 claims description 4
- 239000008363 phosphate buffer Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 239000012847 fine chemical Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000002250 absorbent Substances 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims description 2
- 229960002684 aminocaproic acid Drugs 0.000 claims description 2
- 125000004744 butyloxycarbonyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims description 2
- 238000011046 pyrogen test Methods 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 6
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 5
- 239000010414 supernatant solution Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 239000005909 Kieselgur Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- WPANETAWYGDRLL-UHFFFAOYSA-N 4-aminobenzenecarboximidamide Chemical compound NC(=N)C1=CC=C(N)C=C1 WPANETAWYGDRLL-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 102100039419 Plasminogen activator inhibitor 2 Human genes 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- -1 agarose Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 108010065822 urokinase inhibitor Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP232777A JPS5388389A (en) | 1977-01-14 | 1977-01-14 | Urokinase adsorbent and preparation of highly pure urokinase |
JP945077A JPS5395190A (en) | 1977-01-31 | 1977-01-31 | Production of urokinase adsorbent and high purity urokinase |
JP5292577A JPS53137890A (en) | 1977-05-09 | 1977-05-09 | Preparation of protein adsorptive and high purity urokinase that use said adsorptive |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1585725A true GB1585725A (en) | 1981-03-11 |
Family
ID=27275302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB121578A Expired GB1585725A (en) | 1977-01-14 | 1978-01-12 | Protein adsorbent and process for the production of urokinase |
Country Status (4)
Country | Link |
---|---|
DK (1) | DK147946C (enrdf_load_stackoverflow) |
FR (1) | FR2377415A1 (enrdf_load_stackoverflow) |
GB (1) | GB1585725A (enrdf_load_stackoverflow) |
NL (1) | NL7800200A (enrdf_load_stackoverflow) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2121050A (en) * | 1979-07-05 | 1983-12-14 | Genentech Inc | Preparation of functional human urokinase proteins |
US5112755A (en) * | 1982-04-15 | 1992-05-12 | Genentech, Inc. | Preparation of functional human urokinase proteins |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3746622A (en) * | 1971-05-12 | 1973-07-17 | Xerox Corp | Composition and process |
JPS5276481A (en) * | 1975-12-18 | 1977-06-27 | Otsuka Pharmaceut Co Ltd | Production of high purity urokinase |
-
1978
- 1978-01-06 NL NL7800200A patent/NL7800200A/xx not_active Application Discontinuation
- 1978-01-12 GB GB121578A patent/GB1585725A/en not_active Expired
- 1978-01-13 DK DK17978A patent/DK147946C/da not_active IP Right Cessation
- 1978-01-13 FR FR7800949A patent/FR2377415A1/fr active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2121050A (en) * | 1979-07-05 | 1983-12-14 | Genentech Inc | Preparation of functional human urokinase proteins |
US5112755A (en) * | 1982-04-15 | 1992-05-12 | Genentech, Inc. | Preparation of functional human urokinase proteins |
Also Published As
Publication number | Publication date |
---|---|
FR2377415B1 (enrdf_load_stackoverflow) | 1981-02-27 |
DK147946C (da) | 1985-07-08 |
DK17978A (da) | 1978-07-15 |
FR2377415A1 (fr) | 1978-08-11 |
NL7800200A (nl) | 1978-07-18 |
DK147946B (da) | 1985-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4257938A (en) | Purification method of human fibroblast interferon | |
US4172071A (en) | Chromophore blue adsorbent method for the purification of preparations having an interferon type activity | |
JPH0480886B2 (enrdf_load_stackoverflow) | ||
CA2024667C (en) | Process for preparing a concentrate of blood coagulation factor viii-von willebrand factor complex from total plasma | |
US4119774A (en) | Heparin purification method | |
JPH07267997A (ja) | IgG− モノクロナール抗体の精製方法及びその使用方法 | |
US4259448A (en) | Protein adsorbent and process for the purification of urokinase | |
US4020268A (en) | Agarose containing affinity matrix materials | |
JPH0427504B2 (enrdf_load_stackoverflow) | ||
JPS5832591B2 (ja) | ウロキナ−ゼの精製法 | |
US4321363A (en) | Adsorbent for urokinase containing agarose | |
GB1585725A (en) | Protein adsorbent and process for the production of urokinase | |
US4225675A (en) | Adsorbent for urokinase and process for the production of urokinase | |
SU644796A1 (ru) | Способ очистки протеолитических ферментов | |
US4307228A (en) | Protein adsorbent and process for the purification of urokinase | |
WO1981001417A1 (en) | Isolation of plasminogen activators useful as therapeutic and diagnostic agents | |
JP2521551B2 (ja) | 抗血友病因子の製造方法 | |
US3732146A (en) | Process for the isolation of native, highly purified plasminogen | |
CA1079272A (en) | Method for the purification of heparin | |
Pathak et al. | Effect of activation methods on affinity chromatography of potato polyphenol oxidase | |
JPS606191A (ja) | 低分子ウロキナ−ゼと高分子ウロキナ−ゼの分離方法 | |
GB1601744A (en) | Processes for the purification of interferon certain new and useful intermediates formed therein the purified interferon thus produced and pharmaceutical compositions containing | |
JPS5840472B2 (ja) | カリクレイン含有液中のキニン分解酵素の除去法 | |
JPH0260316B2 (enrdf_load_stackoverflow) | ||
US20030148488A1 (en) | Method for the production of pure virally inactivated butyrylcholinesterase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |